Important Role of the GLP-1 Axis for Glucose Homeostasis after Bariatric Surgery
Citations Over TimeTop 1% of 2019 papers
Abstract
Bariatric surgery is widely used to treat obesity and improves type 2 diabetes beyond expectations from the degree of weight loss. Elevated post-prandial concentrations of glucagon-like peptide 1 (GLP-1), peptide YY (PYY), and insulin are widely reported, but the importance of GLP-1 in post-bariatric physiology remains debated. Here, we show that GLP-1 is a major driver of insulin secretion after bariatric surgery, as demonstrated by blocking GLP-1 receptors (GLP1Rs) post-gastrectomy in lean humans using Exendin-9 or in mice using an anti-GLP1R antibody. Transcriptomics and peptidomics analyses revealed that human and mouse enteroendocrine cells were unaltered post-surgery; instead, we found that elevated plasma GLP-1 and PYY correlated with increased nutrient delivery to the distal gut in mice. We conclude that increased GLP-1 secretion after bariatric surgery arises from rapid nutrient delivery to the distal gut and is a key driver of enhanced insulin secretion.
Related Papers
- → The ventromedial hypothalamic nucleus: watchdog of whole-body glucose homeostasis(2022)45 cited
- → CNS GLP-1 regulation of peripheral glucose homeostasis(2008)64 cited
- → The impact of hypoxia exposure on glucose homeostasis in metabolically compromised humans: A systematic review(2021)23 cited
- → Long Term Improvement of Glucose Homeostasis by Vanadate in Obese Hyperinsulinemic fa/fa Rats*(1989)125 cited
- → The Measurement of Whole-Body Glucose Homeostasis in Mice(2020)1 cited